Cargando…

A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting

SIMPLE SUMMARY: Around 30–40% of patients with early stage colorectal cancer (eCRC) experience relapse after surgery. Current recommendations for adjuvant therapy are based on suboptimal risk-stratification tools. In elderly patients, risk of relapse assessment is particularly important to ultimatel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Donato, Samantha, Vignoli, Alessia, Biagioni, Chiara, Malorni, Luca, Mori, Elena, Tenori, Leonardo, Calamai, Vanessa, Parnofiello, Annamaria, Di Pierro, Giulia, Migliaccio, Ilenia, Cantafio, Stefano, Baraghini, Maddalena, Mottino, Giuseppe, Becheri, Dimitri, Del Monte, Francesca, Miceli, Elisangela, McCartney, Amelia, Di Leo, Angelo, Luchinat, Claudio, Biganzoli, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199587/ https://www.ncbi.nlm.nih.gov/pubmed/34199435 http://dx.doi.org/10.3390/cancers13112762

Ejemplares similares

Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer
por: Vignoli, Alessia, et al.
Publicado: (2021)

Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification
por: McCartney, Amelia, et al.
Publicado: (2019)

The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy
por: De Santo, Irene, et al.
Publicado: (2019)

Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients
por: Risi, Emanuela, et al.
Publicado: (2022)

PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer
por: Migliaccio, Ilenia, et al.
Publicado: (2022)

An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06)
por: Risi, Emanuela, et al.
Publicado: (2019)

Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?
por: Rossi, Lorenzo, et al.
Publicado: (2018)

Cell-Free DNA-Methylation-Based Methods and Applications in Oncology
por: Galardi, Francesca, et al.
Publicado: (2020)

Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice
por: McCartney, Amelia, et al.
Publicado: (2019)

Exploration of Blood Metabolite Signatures of Colorectal Cancer and Polyposis through Integrated Statistical and Network Analysis
por: Di Cesare, Francesca, et al.
Publicado: (2023)

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial
por: Rossi, Lorenzo, et al.
Publicado: (2019)

Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial
por: Galardi, Francesca, et al.
Publicado: (2021)

The role of abemaciclib in treatment of advanced breast cancer
por: McCartney, Amelia, et al.
Publicado: (2018)

Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction?
por: McCartney, Amelia, et al.
Publicado: (2018)

Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer
por: Ghini, Veronica, et al.
Publicado: (2020)

Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer
por: Migliaccio, Ilenia, et al.
Publicado: (2021)

Differential Network Analysis Reveals Molecular Determinants Associated with Blood Pressure and Heart Rate in Healthy Subjects
por: Vignoli, Alessia, et al.
Publicado: (2020)

Potential through simplicity: thymidine kinase-1 as a biomarker for CDK4/6 inhibitors
por: McCartney, Amelia, et al.
Publicado: (2020)

Exploration of Blood Lipoprotein and Lipid Fraction Profiles in Healthy Subjects through Integrated Univariate, Multivariate, and Network Analysis Reveals Association of Lipase Activity and Cholesterol Esterification with Sex and Age
por: Balder, Yasmijn, et al.
Publicado: (2021)

Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers
por: Migliaccio, Ilenia, et al.
Publicado: (2015)

A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer
por: Malorni, Luca, et al.
Publicado: (2016)

Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy
por: Vignoli, Alessia, et al.
Publicado: (2020)

Age- and Sex-Dependent Changes of Free Circulating Blood Metabolite and Lipid Abundances, Correlations, and Ratios
por: Di Cesare, Francesca, et al.
Publicado: (2021)

Association of Plasma Metabolites and Lipoproteins with Rh and ABO Blood Systems in Healthy Subjects
por: Di Cesare, Francesca, et al.
Publicado: (2022)

ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data
por: Romagnoli, Dario, et al.
Publicado: (2018)

Serum or Plasma (and Which Plasma), That Is the Question
por: Vignoli, Alessia, et al.
Publicado: (2022)

Charting differentially methylated regions in cancer with Rocker-meth
por: Benelli, Matteo, et al.
Publicado: (2021)

Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy
por: Bonechi, Martina, et al.
Publicado: (2018)

The best treatment for older patients with breast cancer
por: Turner, Natalie, et al.
Publicado: (2013)

Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer
por: Guarducci, Cristina, et al.
Publicado: (2018)

Duodenocaval fistula after bevacizumab therapy: case presentation and complete overview of the literature
por: Giordano, Alessio, et al.
Publicado: (2023)

High‐Throughput Metabolomics by 1D NMR
por: Vignoli, Alessia, et al.
Publicado: (2018)

EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer
por: Biganzoli, Laura, et al.
Publicado: (2020)

Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
por: Vignoli, Alessia, et al.
Publicado: (2022)

Novel metabolomics-biohumoral biomarkers model for predicting survival of metastatic soft-tissue sarcomas
por: Vignoli, Alessia, et al.
Publicado: (2023)

Evidence of a DHA Signature in the Lipidome and Metabolome of Human Hepatocytes
por: Ghini, Veronica, et al.
Publicado: (2017)

Classifying sepsis from photoplethysmography
por: Lombardi, Sara, et al.
Publicado: (2022)

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD
por: Montuschi, Paolo, et al.
Publicado: (2018)

A Metabolomic Perspective on Coeliac Disease
por: Calabrò, Antonio, et al.
Publicado: (2014)

Sarcolab pilot study into skeletal muscle’s adaptation to long-term spaceflight
por: Rittweger, Jörn, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8liu91d9sbif9k9835hea881l7